Position in ALNY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$992
-$996 QoQ
Shares Held
3
-40.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026High Note Wealth, LLC holds $102,652 across 8 Biotechnology names. ALNY ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93 | $41,528 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
1,500 | $28,350 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21 | $16,225 | |
| 4 | CYTK |
Cytokinetics Inc
|
118 | $7,777 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
71 | $4,837 | |
| 6 | CNTN |
Canton Strategic Holdings, Inc.
|
600 | $1,962 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3 | $992 | |
| 8 | INSM |
INSMED Inc
|
6 | $981 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $992 | 3 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,988 | 5 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||